Lincoln Pharmaceuticals has scheduled its 32nd Annual General Meeting for September 30, 2026, to approve a final dividend of ₹1.80 per equity share for the fiscal year ended March 31, 2026. The payout represents an 18% dividend on the face value of ₹10 per share.

The meeting will be conducted via video conferencing or other audio-visual means in accordance with Ministry of Corporate Affairs circulars. The book closure period runs from September 12, 2026, to September 30, 2026, with shareholders holding shares as of September 11, 2026, eligible for the dividend if approved.

Key Resolutions

The agenda includes ordinary and special business items requiring shareholder consent:

• Re-appointment of Whole Time Directors Mr. Hashmukh I. Patel and Mr. Munjal Mahendrabhai Patel, who retire by rotation.
• Ratification of remuneration for Kiran J. Mehta & Co., Cost Accountants, at ₹2,50,000 per annum plus applicable taxes and out-of-pocket expenses for the audit of cost records for FY27.

Director Profiles

The notice provides details on the directors seeking re-appointment:

Mr. Munjal Mahendrabhai Patel is the son of Managing Director Mr. Mahendra G. Patel. He also serves as an Independent Director at Mamata Machinery Limited.

Voting and Logistics

Remote e-voting opens on September 26, 2026, at 9:00 am and closes on September 29, 2026, at 5:00 pm. Shareholders can participate through CDSL or NSDL depository platforms. The company has appointed Parikh Dave & Associates as the scrutinizer for the e-voting process.

Tax deduction at source (TDS) will apply to dividend payments. Resident shareholders without a valid PAN face a 20% withholding tax, while those with valid PANs are subject to a 10% rate. Non-resident shareholders must provide Tax Residency Certificates to avail benefits under double tax avoidance agreements.

Lincoln Pharmaceuticals has announced the record date for its 32nd Annual General Meeting. The company will hold the meeting on September 30, 2026, via video conferencing or other audio-visual means.

Book Closure and Record Date

The record date is set for Friday, September 11, 2026. The book closure period runs from Saturday, September 12, 2026, through Wednesday, September 30, 2026. This determines eligibility for shareholders to receive dividends if approved at the AGM.

Dividend Proposal

The company proposes a final dividend of ₹1.80 per equity share. This represents an 18% payout on the face value of ₹10. The dividend applies to the financial year ending March 31, 2026.

Payment of the final dividend is subject to approval by members at the AGM. Trusha Shah, Company Secretary and Compliance Officer, issued the intimation on August 29, 2026, pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.